Dow Down0.02% Nasdaq Up0.07%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
33.03 Down 0.03(0.09%) Nov 25, 4:00PM EST
|After Hours : 33.03 Down 0.00 (0.01%) Nov 25, 4:35PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 155,592   130,644   101,645  
Cost of Revenue3,596   -  3,043  
Gross Profit 151,996   130,644   98,602  
Operating Expenses
Research Development85,421  94,839  73,831  
Selling General and Administrative68,070  36,929  24,226  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (1,495) (1,124) 545  
Income from Continuing Operations
Total Other Income/Expenses Net111  587  942  
Earnings Before Interest And Taxes(1,384)(537)1,487  
Interest Expense11,938  18,198  37,736  
Income Before Tax(13,322)(18,735)(36,249)
Income Tax Expense182   -  18  
Minority Interest -   -   -  
Net Income From Continuing Ops(13,504)(18,735)(36,267)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (13,504) (18,735) (36,267)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (13,504) (18,735) (36,267)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.